GRI Bio
GRI
GRI Bio (GRI) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$35.84
- EPS estimate
- −$31.08
- EPS surprise
- −15.32%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 14, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 14, 2025 | −$31.08 | −$35.84 | −15.32% | $0.00 | SEC |
| Q2 2025 | Aug 14, 2025 | −$36.68 | −$36.68 | +0.00% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$105.98 | −$162.40 | −53.24% | $0.00 | SEC |
| Q4 2024 | Mar 14, 2025 | −$152.32 | −$218.26 | −43.29% | $0.00 | SEC |
| Q3 2024 | Nov 14, 2024 | −$347.48 | −$318.92 | +8.22% | $0.00 | SEC |
| Q2 2024 | Aug 14, 2024 | $0.00 | −$2,341.92 | +0.00% | $0.00 | SEC |
| Q2 2022 | Jul 28, 2022 | −$298,880.40 | −$259,896.00 | +13.04% | $0.00 | SEC |
| Q4 2021 | Feb 14, 2022 | −$285,885.60 | −$285,885.60 | +0.00% | $0.00 | SEC |
| Q3 2021 | Nov 12, 2021 | $0.00 | −$233,906.40 | +0.00% | $0.00 | SEC |
| Q2 2021 | Aug 10, 2021 | $0.00 | −$441,823.20 | +0.00% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did GRI Bio (GRI) last report earnings?
GRI Bio last reported on Nov 14, 2025, covering fiscal Q3 2025.
Did GRI beat earnings estimates?
No. GRI Bio reported EPS of −$35.84 for Q3 2025 against a −$31.08 estimate — a 15.32% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.